For so long, the life sciences scene in New York has been missing a key ingredient needed for any biotech hub to flourish--the full attention of biotech venture capitalists. That, however, is changing fast. Over the past year, New York’s radical biotech transformation has drawn some of the country’s best-known life science company creators into the big city with big dollars to spend. And they’ve started putting that money to work by forming some of the most high-profile startups the city has seen in some time.

Join Xconomy at the Alexandria Center for Life Science. We’re taking this important topic head on with a unique, interactive evening featuring a trio of candid stories and insights from some of the area's top innovators, researchers, and venture backers committed to turning New York into the nation’s next great biotech cluster.

Opening Remarks

Joel Marcus
Chairman, CEO, and Founder, Alexandria Real Estate Equities

Lodo Therapeutics and Petra Pharma Stories

Sean Brady
Associate Professor, The Rockefeller University
Scientific Founder, Lodo Therapeutics

Lewis Cantley
Director, Meyer Cancer Center, Weill Cornell Medical College
Co-founder, Petra Pharma

David Schubert
COO, Accelerator Corporation

Prasad Kodali
Global Solutions & Strategy Leader for Life Sciences, IBM

Kallyope Story

Nancy Thornberry
CEO, Kallyope

Charles Zuker
Professor, Columbia University Medical Center
Co-founder, Kallyope

Adam Goulburn
Partner, Lux Capital

NYC Life Sciences Fund Story

Doug Cole
Managing Partner, Flagship Ventures

Twitter:
@Xconomy
#xcondisrupt

Schedule:
Registration & Networking: 5:00 – 6:00 pm
Program: 6:00 – 7:45 pm
Networking Reception: 7:45 – 8:45 pm
Full agenda

Registration:
Tickets are transferable but not refundable.
To inquire about press registration, e-mail events@xconomy.com.

Speakers and program schedule are subject to change.

EVENT HOST

PLATINUM SPONSOR

GOLD SPONSORS

SILVER SPONSOR

NATIONAL PARTNER

Alexandria Real Estate Equities

CHARTER UNDERWRITER
Biogen

UNDERWRITERS
EisnerAmper • Johnson & Johnson Innovation
Sarepta Therapeutics • Texas Medical Center

VENTURE CAPITAL MEMBERS
Atlas Venture • Avalon Ventures • Boston Millennia Partners • Flagship Ventures
LaunchCapital • Santé Ventures • SR One • Third Rock Ventures

LIFE SCIENCE MEMBERS
Acorda Therapeutics • Alnylam Pharmaceuticals
Arrowhead Research • Bayer • CRG
Genocea Biosciences • Health Advances • LabConnect